Drug intelligence / Profile preview

apigenin

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Apigenin is a naturally occurring flavonoid (specifically a flavone) found in many plants such as chamomile, parsley, celery, and others. It is known for its antioxidant and anti-inflammatory properties. Preclinical studies suggest that apigenin may reduce anxiety by modulating GABA receptors in the brain and may support healthy aging by inhibiting CD38 to preserve NAD+ levels important for DNA repair and metabolism. Apigenin also exhibits antibacterial, antiviral, antifungal, antiparasitic activities and has been studied for potential neuroprotective effects against diseases like Alzheimer’s and Parkinson’s. While it shows promise in animal models for improving sleep quality and reducing tumor proliferation through various mechanisms—including modulation of inflammatory pathways like NF-kB—there are limited human clinical trials on isolated apigenin[1][2][3][4][5].

Other names
4′,5,7-trihydroxyflavone5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyroneapigenolapigeninechamomile (as a source)5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one
02

Targets

CD38 (Cluster of Differentiation 38)IKK complexGABRR (GABA-A receptor subunit rho)

Beyond the preview

Go deeper on apigenin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on apigenin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call